Advertisement Iomai stockholders approve merger with Intercell subsidiary - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Iomai stockholders approve merger with Intercell subsidiary

Iomai has announced that its stockholders approved the merger of the company with a wholly-owned subsidiary of Intercell.

Approximately 71.6% of Iomai’s outstanding shares entitled to vote at the special meeting approved the merger, representing approximately 99.9% of the votes cast.

The transaction remains subject to certain closing conditions. Assuming satisfaction of the remaining conditions, the transaction is anticipated to be completed on or about August 5, 2008.